Catalog No. | CF977016 |
---|---|
Species reactivity | Dog |
Applications | Research Grade Biosimilar |
Host species | Caninized |
Isotype | IgG2, kappa |
Expression system | Mammalian Cells |
Clonality | Monoclonal |
Target | TGFB1/TGF-beta-1 |
Concentration | 1mg/ml |
Endotoxin level | Please contact the lab for this information. |
Purity | >95% purity as determined by SDS-PAGE. |
Purification | Protein A/G, purified from cell culture supernatant. |
Accession | P54831 |
Form | Liquid |
Storage buffer | 0.01M PBS,pH7.4. |
Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -1360°C. |
Alternate Names | ZTS00521426,ZTS-00521426,ZTS00521426,CAS:2473240-98-9 |
Background | Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator. |
Note | For research use only. Not for use in clinical or therapeutic applications. |
+33(0)3 90 20 54 70
19 rue de la Haye 67300 Schiltigheim France